Insider buying
~$15K5,000 sh @ $3.00
1 day before an 8-KTraded Nov 16 · filed 2 days later
Since the trade
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Checked for new insider filings 3 h ago
Guides: What is an SEC Form 4 · the transaction codes · who has to file · 10b5-1 plans
Worth a look: purchases of $10K+ and sales of $250K+ not reported under a pre-arranged trading plan.
Insider buying
1 day before an 8-KTraded Nov 16 · filed 2 days later
Since the trade
Bought 48% below the 52-week high, RSI 41, 16% under its 200-day average, 31 points behind the S&P 500 over 3 months
A Nephros director paid $15K out of pocket for Nephros shares.
Lately at Nephros: it changed a top executive or board member on Nov 17; the stock is down 27% in 30 days.
Traded Nov 16 – Nov 18, 2026 · largest single transaction ~$663KNot reported under a pre-arranged trading plan
Lately at First Watch Restaurant Group: it reported its results on Nov 3; the stock is 38% below its 12-month high; insiders made no purchase ($10K+) and 3 large sales ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$663K · 50K sh @ $13.25
DetailsOfficial recordNov 18, 2026~$624K · 47K sh @ $13.16
DetailsOfficial recordInsider selling
Traded Nov 18 · filed the same day
An Aura Minerals insider told the SEC about a plan to sell $1.08M of Aura Minerals shares around Nov 18, 2026. The shares were not acquired as compensation. That is a tiny part of all Aura Minerals shares.
Lately at Aura Minerals: the stock rose 13% in one session on Nov 4 with press coverage; the stock is down 33% in 30 days; insiders made 4 purchases ($10K+) and 37 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −4.6% · S&P 500 −6.8% · to Nov 20
A Lifestance Health director sold $1.78M of Lifestance Health shares. The filing does not indicate a pre-arranged trading plan.
Lately at Lifestance Health: it reported its results on Nov 5; the stock is up 12% in 30 days; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −3.7% · S&P 500 −6.8% · to Nov 20
Spectrum Brands's GC & Corporate Secretary sold $2.3M of Spectrum Brands shares. The filing does not indicate a pre-arranged trading plan.
Lately at Spectrum Brands Holdings: it reported its results on Nov 12; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −12.0% · S&P 500 −6.8% · to Nov 20
A Loar director sold $1.7M of Loar shares. The filing does not indicate a pre-arranged trading plan.
Lately at Loar: it reported its results on Nov 5; insiders made no purchase ($10K+) and 10 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −12.0% · S&P 500 −6.8% · to Nov 20
A Loar director sold $1.7M of Loar shares. The filing does not indicate a pre-arranged trading plan.
Lately at Loar: it reported its results on Nov 5; insiders made no purchase ($10K+) and 10 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −12.0% · S&P 500 −6.8% · to Nov 20
A Loar director sold $1.7M of Loar shares. The filing does not indicate a pre-arranged trading plan.
Lately at Loar: it reported its results on Nov 5; insiders made no purchase ($10K+) and 10 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −7.1% · S&P 500 −5.8% · to Nov 20
An Advanced Drainage Systems director sold $1.7M of Advanced Drainage Systems shares. The filing does not indicate a pre-arranged trading plan.
Lately at Advanced Drainage Systems: the stock fell 15% in one session on Nov 5 around a company release; it signed an important agreement on Nov 10; the stock is down 15% in 30 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −12.0% · S&P 500 −6.8% · to Nov 20
A Loar director sold $1.7M of Loar shares. The filing does not indicate a pre-arranged trading plan.
Lately at Loar: it reported its results on Nov 5; insiders made no purchase ($10K+) and 10 large sales ($250K+, not pre-arranged) in 90 days.
Traded Nov 16 – Nov 17, 2026 · largest single transaction ~$5.11MNot reported under a pre-arranged trading plan
Lately at Roivant Sciences: it reported its results on Nov 9; the stock is up 5% in 30 days; insiders made no purchase ($10K+) and 22 large sales ($250K+, not pre-arranged) in 90 days.
Nov 16, 2026~$5.11M · 131K sh @ $38.99
DetailsOfficial recordNov 16, 2026~$3.11M · 79K sh @ $39.17
DetailsOfficial recordNov 17, 2026~$2.9M · 76K sh @ $38.24
DetailsOfficial recordInsider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −4.2% · S&P 500 −6.8% · to Nov 20
Ibex's Chief Operating Officer sold $1.6M of Ibex shares. The filing does not indicate a pre-arranged trading plan.
Lately at Ibex: the stock rose 15% in one session on Nov 6 around a company release; it reported its results on Nov 5; the stock is up 15% in 30 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −3.3% · S&P 500 −6.8% · to Nov 20
A Regeneron Pharmaceuticals director sold $960K of Regeneron Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Lately at Regeneron Pharmaceuticals: the stock rose 13% in one session on Oct 30 around a company release; it reported its results on Oct 30; the stock is up 14% in 30 days.
Insider selling
Traded Nov 17 · filed 1 day laterNot reported under a pre-arranged trading plan
Since the trade −2.8% · S&P 500 −5.8% · to Nov 20
A Community West Bancshares director sold $981K of Community West Bancshares shares. The filing does not indicate a pre-arranged trading plan.
Lately at Community West Bancshares: it reported its results on Oct 22; the stock is down 6% in 30 days; insiders made 4 purchases ($10K+) and 1 large sale ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −0.1% · S&P 500 −6.8% · to Nov 20
O'Reilly Automotive's SVP OF MERCHANDISE sold $1.27M of O'Reilly Automotive shares. The filing does not indicate a pre-arranged trading plan.
Lately at O'Reilly Automotive: it reported its results on Oct 28; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days; members of Congress disclosed no purchase and 2 sales in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −3.7% · S&P 500 −6.8% · to Nov 20
A Spectrum Brands director sold $821K of Spectrum Brands shares. The filing does not indicate a pre-arranged trading plan.
Lately at Spectrum Brands Holdings: it reported its results on Nov 12; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days.
Insider selling
Traded Nov 16 · filed 2 days laterNot reported under a pre-arranged trading plan
Since the trade −9.8% · S&P 500 −6.8% · to Nov 20
A Universal Electronics director sold $810K of Universal Electronics shares. The filing does not indicate a pre-arranged trading plan.
Lately at Universal Electronics: the stock rose 14% in one session on Nov 11 with press coverage; it reported its results on Nov 5; insiders made no purchase ($10K+) and 5 large sales ($250K+, not pre-arranged) in 90 days.